Venture Capital Trends & Family Office Activity
- Family office direct investment strategies and co-investments
- LP/GP dynamics and late-stage funding in tech and bio
- M&A, strategic roll-ups, and corporate venture capital
April 15-16, 2027 · Nashville, TN
Frontiers 2027
Phase Capital's fourth annual summit bringing together a curated group of founders, investors, scientists, and leaders at the intersection of tech, bio, and data science.
Early bird pricing ends March 1, 2027. Prices increase by $300 after.
Active investor? Apply for a complimentary Investor Pass.
Last year's conference by the numbers
170+
Attendees
51+
Cities
$27B+
AUM
33
Speakers
14
Companies in the Pitch Showcase
2
Astronauts on Stage
“Not every day you get to grab drinks with a NASA astronaut, a pathologist, investors, entrepreneurs/colleagues pushing the frontiers of biology, tech, big data and space, and friends from across the broader ecosystem, all in one place.”
ABOUT THE CONFERENCE
Frontiers
Frontiers is Phase Capital's flagship summit. After hosting 25+ events across North America, we built two days that bring executives, founders, early-stage entrepreneurs, scientists, and investors together for two purposes:
‣ explore what's coming next (hence the title of the conference: Frontiers)
‣ build business outcomes on real relationships.
The goal is to have every spoke of the biotech and healthcare innovation flywheel represented. This has historically led to investments, hires, partnerships, and even new companies. The summit has grown from 150 attendees in year one to a cap of 250 in year four. We keep it intentionally small, and every aspect, from roundtables to an invitation-only speaker / sponsor reception, is designed to encourage authentic relationships with strong business outcomes.
Our founder, Dr. Kavya Sharman, is a big believer in the idea that spending time around art and music sparks creativity, so we weave in opera, live music, Nashville hot chicken, microgreens, and wine tastings alongside cutting-edge science and biotech.
Frontiers 2027
Frontiers 2027 Focus Areas
Capital trends and activity alongside technological advancements in tech bio.
Physical AI & Autonomous Science
- Embodied AI, lab automation, and robotics
- Closed-loop scientific discovery and automated wet labs
- Biomanufacturing and hardware infrastructure
TechBio Breakthroughs & Commercialization
- AI-native drug discovery and next-generation diagnostics
- Translating academic research into commercial ventures
- Space biology, synthetic biology, and multi-omics
More to come.
Frontiers 2027
Frontiers 2027: Confirmed Speakers
April 15-16, 2027 · Nashville, TN · Capped at 250
Additional speakers announced throughout 2026.
Speaker lineup subject to change.
The Room
Who attends Frontiers
Bringing together executives and leaders from every spoke of the innovation flywheel.
Active Investors
GPs, Managing Partners, and check-writers who have made at least one investment in the last 12 months.
Founders and CEOs (pre-seed through publicly traded companies)
GPs, Partners, and MDs (active check writers)
Angel groups and family offices
Health system and pharma leaders (VP and above)
Scientists and researchers
Senior industry partners (CROs, CDMOs, law firms, financial services)
Policy and regulatory leaders
Attendance is capped at 250 to facilitate meaningful conversations and authentic connections.
Previous attending institutions
Memorial Sloan Kettering Cancer CenterRA Capital ManagementMD Anderson Cancer CenterXontogenyDraperU VenturesThird Rock VenturesModernaRegeneronMayo ClinicDana-Farber Cancer InstituteOracle NetSuiteSarah Cannon Research InstituteVanderbilt UniversityForm BioStanford UniversityFlatiron Law GroupCDD VaultSikichCherry BekaertNashville Area Chamber of CommerceNashville Entrepreneur CenterTennessee Department of Economic and Community DevelopmentBioCenturyAmerican Cancer SocietyMemorial Sloan Kettering Cancer CenterRA Capital ManagementMD Anderson Cancer CenterXontogenyDraperU VenturesThird Rock VenturesModernaRegeneronMayo ClinicDana-Farber Cancer InstituteOracle NetSuiteSarah Cannon Research InstituteVanderbilt UniversityForm BioStanford UniversityFlatiron Law GroupCDD VaultSikichCherry BekaertNashville Area Chamber of CommerceNashville Entrepreneur CenterTennessee Department of Economic and Community DevelopmentBioCenturyAmerican Cancer Society
Previous sponsors
Outcomes
What Happens at Frontiers
As with all our events, the only rule is no pitching or selling - share what you're building or investing in, and the rest will follow.
Investments closed
Funding rounds have come together from relationships built in the room.
Partnerships formed
Companies have signed commercial agreements that started as summit conversations.
Collaborations announced
Frontiers has been the stage for real announcements, including an academic-startup collaboration unveiled at the 2026 summit.
Talent and clients found
Attendees have recruited senior hires and converted introductions into client relationships.
Track Record
A Summit Four Years in the Making
Frontiers has convened biotech's most important conversations since 2023.
2026
Frontiers 2026
170+ attendees, 51+ cities, $27B+ AUM, 33 speakers, 2 astronauts. White paper published.
2025
Frontiers 2025
150+ attendees, 44+ cities. 3+ countries. White paper published.
The Opportunity
Why attend Frontiers 2027
Frontiers is thoughtfully designed to highlight new innovation and market movement in the coming months and create a deal-making platform for those investing and building in biotech and healthcare.
Frontiers attendees have included C-suite executives, founders, and partners. $27B+ in AUM was represented by GPs and Managing Directors last year. Each executive in the room has the ability to meaningfully move things forward: write a check, sign a partnership agreement, or greenlight a pilot.
Phase Capital / Frontiers
Be in the room for Frontiers 2027
April 15-16, 2027 in Nashville. Capped at 250 attendees. Early bird pricing ends March 1, 2027; prices increase by $300 after.